Abstract |
The rate of clearance from the lungs of inhaled technetium-99m labelled diethylene triamine penta- acetic acid (99mTc-DTPA) is often increased in interstitial lung disease as well as in smoking. In smokers a bi-exponential clearance course of 99mTc-DTPA when measured over 3 h has previously been shown. This study was performed to compare the kinetics of clearance of 99mTc-DTPA, measured for 3 h, in sarcoid patients and healthy smokers. Forty-one never-smoking patients with sarcoidosis and radiological signs of intrathoracic disease were studied. The results were compared with those of 16 healthy current smokers and of 14 healthy never-smokers reported previously. A mono-exponential clearance equation described the clearance in 22 of the sarcoid patients and all normal never-smokers, but with a shorter average tracer half-life in the patients (P < 0.05). In 19 patients and all smokers a bi-exponential equation gave a significantly better curve fit. The rate of clearance of the slow component was higher in patients with sarcoidosis than in smokers (P < 0.05). The fraction of the tracer cleared by the fast clearance component was smaller in patients with sarcoidosis than in smokers (P < 0.01). Differences in kinetics of clearance of 99mTc-DTPA in sarcoidosis and smoking could thus be demonstrated, suggesting that the abnormal clearance is caused by diverging pathophysiological mechanisms.
|
Authors | I Brådvik, P Wollmer, E Evander, H Lárusdóttir, B Blom-Bülow, B Jonson |
Journal | European journal of nuclear medicine
(Eur J Nucl Med)
Vol. 21
Issue 11
Pg. 1218-22
(Nov 1994)
ISSN: 0340-6997 [Print] Germany |
PMID | 7859774
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Technetium Tc 99m Pentetate
|
Topics |
- Adult
- Female
- Half-Life
- Humans
- Lung
(diagnostic imaging, physiopathology)
- Male
- Radionuclide Imaging
- Sarcoidosis, Pulmonary
(diagnostic imaging, physiopathology)
- Smoking
(physiopathology)
- Spirometry
- Technetium Tc 99m Pentetate
(pharmacokinetics)
- Time Factors
|